tiprankstipranks
Trending News
More News >
Relmada Therapeutics Inc (RLMD)
NASDAQ:RLMD

Compare Relmada Therapeutics (RLMD) vs. Competitors

Compare
402 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Relmada Therapeutics
$4.11
$278.67M
-2.08
859.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
XBiotech
$2.53
$77.13M
-2.69
-34.96%
Repare Therapeutics
$2.58
$110.79M
-1.52
100.78%
1 Buy
1 Hold
0 Sell
Moderate Buy
Prelude Therapeutics
$2.45
$121.72M
-1.12
108.74%
Spruce Biosciences
$74.89
$80.16M
-0.87
169.51%
4 Buy
0 Hold
0 Sell
Strong Buy
Werewolf Therapeutics
$0.55
$26.74M
-0.34
-60.43%
2 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLMD
Relmada Therapeutics
3.80
3.43
927.03%
XBIT
XBiotech
2.53
-1.29
-33.77%
RPTX
Repare Therapeutics
2.57
1.29
100.78%
PRLD
Prelude Therapeutics
2.15
1.10
104.76%
SPRB
Spruce Biosciences
74.89
47.53
173.72%
HOWL
Werewolf Therapeutics
0.55
-0.78
-58.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts